Celum, Connie, MD

Celum, Connie, MD
Director, International Clinical Research Center for Infectious DiseasesProfessor,
Division of Allergy and Infectious Diseases/ Department of Medicine
Professor, Department of Global Health
Adjunct Professor, Epidemiology

CONTACT INFORMATION
Box 359927
Cabrini Medical Tower, Suite 1300
901 Boren Avenue
Seattle, Washington 98104
Phone: (206) 520-3825
Fax: (206) 520-3831
ccelum@u.washington.edu

LINK TO CONNIE CELUM'S COMMUNITY OF SCIENCE WEB PAGE

Dr. Celum's research currently focuses on HIV prevention, microbicide, and vaccine trials with the objective to find effective strategies to reduce HIV acquisition and transmission. She utilizes epidemiologic data on behavioral and biologic risk factors for HIV acquisition and transmission to identify potential intervention strategies and then to conduct randomized clinical trials to determine safety and efficacy of these interventions with biologic outcome measurements.

Her current focus is on HIV prevention trials, including genital herpes suppression for prevention of HIV acquisition, transmission and pre-exposure antiretroviral prophylaxis.

Dr. Celum is PI of a multi-center efficacy trial of HSV-2 suppression to reduce HIV infectiousness and HIV disease progression among HIV-discordant couples in Africa, and PI of a multi-center efficacy trial of pre-exposure antiretroviral prophylaxis among HIV discordant couples in Kenya and Uganda.

Celum CL, Bolan G, Krone MR, Code K, Leone P, Spaulding C, Henry K, Clarke P, Smith M, Hook EW, 3rd. Patients attending STD clinics in an evolving health care environment. Demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis 1997; 24:599-605.

Gross M, Buchbinder SP, Celum CL, Heagerty P, Seage GR, 3rd. Rectal microbicides for U.S. gay men. Are clinical trials needed? Are they feasible? HIVNET Vaccine Preparedness Study Protocol Team. Sex Transm Dis 1998; 25:296-302.

Wilson SE, Pedersen SL, Kunich JC, Wilkins VL, Mann DL, Mazzara GP, Tartaglia J, Celum CL, Sheppard HW. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res Hum Retroviruses 1998; 14:925-37.

Gross M, Celum CL, Tabet SR, Kelly CW, Coletti AS, Chesney MA. Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide. Sex Transm Dis 1999; 26:572-8.

Gorbach PM, Aral SO, Celum CL, Stoner BP, Whittington WLH, Galea JT, Coronado N, Connor S, Holmes KK. To notify or not to notify: STD patients' perspectives of partner notification in Seattle. Sex Transm Dis 2000; 27:193-200.